Company: BDRX
Filing Date: 2025-06-13
Form Type: 6-K
Source: 0001214659-25-009205
Chunk: 1

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 6-K
Chunk 1
---
 is:

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: June 13, 2025 | Biodexa Pharmaceuticals PLC 
 By:                         | /s/ Stephen Stamp                                   |
|:--------------------|:----------------------------|:----------------------------------------------------|
|                     |                             | Stephen Stamp                                       |
|                     |                             | Chief Executive Officer and Chief Financial Officer |